Experts at Children's Hospital Boston and Dana-Farber Cancer Institute are internationally known for their laboratory and clinical research findings. In addition to offering the most Phase I clinical trials in New England, laboratory researchers at Children's and Dana-Farber examine every aspect of cancer from its scientific origin to molecular response to new drug combinations. As a result, findings from Children's and Dana-Farber have been responsible for dozens of advances in the treatment of pediatric cancer that have resulted in improved survival rates for nearly every variety of childhood cancer.
Key accomplishments include:
|
